|
Delayed
Japan Exchange
02:30:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 2,407.50 JPY | +0.77% |
|
+0.71% | +10.82% |
| 09-01 | Ono Pharmaceutical Co., Ltd. Enters Into Drug Discovery Partnership With Aitia, Inc | CI |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| Market Cap | 1,123B 7.09B 6.22B 5.85B 5.35B 9.99B 679B 10.07B 70.26B 27.24B 346B 26.62B 26.04B | P/E 2027 * |
15.2x | P/E 2028 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 922B 5.82B 5.11B 4.8B 4.39B 8.2B 557B 8.26B 57.67B 22.36B 284B 21.85B 21.38B | EV / Sales 2027 * |
2.01x | EV / Sales 2028 * | 1.95x |
| Free-Float |
81.92% | Yield 2027 * |
3.28% | Yield 2028 * | 3.25% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4528 | Delayed | |
OTC Markets
| OPHLF | Delayed | |
|
Tradegate
| ON4 | Real-time | |
|
Börse Stuttgart
| ON4 | Delayed | |
|
Boerse Muenchen
| ON4 | Real-time | |
|
Deutsche Boerse AG
| ON4 | Delayed |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +0.52% | ||
| 1 week | +0.46% | ||
| Current month | -2.00% | ||
| 1 month | -1.74% | ||
| 3 months | +2.19% | ||
| 6 months | +0.59% | ||
| Current year | +10.54% |
| 1 week | 2,376 |  | 2,415 |
| 1 month | 2,290.5 | | 2,517.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,674 | | 2,674.5 |
| 3 years | 1,474 | | 2,894 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.77% | +0.46% | +39.34% | -15.63% | 7.09B | |
| -0.03% | -0.36% | +14.34% | +65.52% | 46.71B | |
| -0.72% | -2.71% | +34.66% | +103.39% | 36.9B | |
| +1.23% | +3.81% | +13.75% | +95.31% | 12.18B | |
| +1.56% | +1.83% | -8.88% | +18.84% | 11.66B | |
| +0.19% | -0.95% | +20.37% | +140.74% | 8.97B | |
| -0.85% | +1.54% | +21.53% | +212.30% | 7.29B | |
| +0.56% | +0.56% | +26.32% | +37.72% | 7.21B | |
| -0.64% | +4.03% | -43.43% | +10.76% | 5.12B | |
| +0.06% | +1.93% | +40.96% | +112.20% | 4.65B | |
| Average | -0.02% | +1.58% | +15.90% | +78.11% | 14.78B | |
| Weighted average by Cap. | -0.34% | +0.72% | +18.88% | +79.88% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 459B 2.9B 2.54B 2.39B 2.19B 4.09B 278B 4.12B 28.72B 11.14B 142B 10.88B 10.65B | 448B 2.83B 2.48B 2.34B 2.13B 3.99B 271B 4.02B 28.05B 10.87B 138B 10.63B 10.4B |
| Net income | 74B 467M 410M 386M 353M 659M 44.77B 664M 4.63B 1.8B 22.82B 1.75B 1.72B | 63.81B 403M 354M 332M 304M 568M 38.6B 572M 3.99B 1.55B 19.68B 1.51B 1.48B |
| Net Debt | -201B -1.27B -1.11B -1.05B -958M -1.79B -122B -1.8B -12.59B -4.88B -62.02B -4.77B -4.66B | -250B -1.58B -1.38B -1.3B -1.19B -2.22B -151B -2.24B -15.63B -6.06B -77.01B -5.92B -5.79B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | JP¥2,407.50 | +0.77% | 1,906,200 |
| 26-09-18 | JP¥2,389.00 | -0.06% | 2,461,300 |
| 26-09-17 | JP¥2,390.50 | +2.60% | 1,298,200 |
| 26-09-16 | JP¥2,330.00 | -1.00% | 1,083,800 |
| 26-09-15 | JP¥2,353.50 | +0.68% | 1,053,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
